BUSINESS
FDA Approves Lilly’s Foundayo Weight-Loss Pill, Challenging Novo Nordisk
The FDA approved Eli Lilly’s oral weight-loss pill Foundayo, competing with Novo Nordisk’s Wegovy. Foundayo offers 12-15% weight loss and launches April 6.